Metabolic surgery for type II diabetes: an update

Area of Science:

• Metabolic Surgery
• Endocrinology
• Bariatric Procedures

Background:

• Bariatric operations are recognized for improving Type II Diabetes Mellitus (T2DM) and associated comorbidities.
• Evidence from clinical trials supports surgical interventions for T2DM remission or significant improvement.

Purpose of the Study:

• To review randomized trials and meta-analyses from the past 20 years on bariatric/metabolic surgery outcomes in obese patients with type 2 diabetes.
• To highlight the available scientific evidence on the efficacy of these procedures.

Main Methods:

• Review of randomized controlled trials (RCTs) and meta-analyses published over the last two decades.
• Analysis of studies focusing on bariatric/metabolic surgery in obese patients with T2DM, including those with BMI > 35 kg/m² and BMI < 35 kg/m².

Main Results:

• Bariatric/metabolic surgery demonstrates outstanding results in managing Type II diabetes and comorbidities.
• Procedures are superior to non-surgical interventions for weight loss and diabetes amelioration, even in patients with a BMI of 30-35 kg/m².
• Improved glycemic control is observed across various procedures including sleeve gastrectomy, duodenal-jejunal bypass, and Roux-en-Y gastric bypass.

Conclusions:

• Bariatric surgery is a highly effective treatment for Type II diabetes and associated conditions.
• The precise physiopathological mechanisms improving glucose homeostasis post-surgery require further elucidation.
• Metabolic surgery should be considered a complementary strategy alongside conservative treatments for optimal diabetes control and potential cure.